GeneInCell

Optogenetics has transformed neuroscience by letting scientists control specific nerve cells with light. In this episode, we explore the discoveries behind the 2026 Nobel Prize in Physiology or Medicine, how light-sensitive ion channels became powerful tools for mapping brain circuits, and how optogenetics is opening new possibilities for understanding—and potentially treating neurological and sensory disorders.

AlphaGenome Atlas is helping decode the 98% of the human genome that doesn’t code for proteins. By predicting how non-coding variants affect transcription, splicing, chromatin accessibility, and gene regulation, it can prioritize potentially harmful mutations, clarify rare disease cases, and reveal regulatory mechanisms hidden in the “dark genome.”

Can mRNA vaccines train the immune system to recognize and attack cancer? In this episode, we explore how mRNA cancer vaccines are designed, how they deliver tumor-specific instructions to immune cells, and why personalized neoantigen vaccines are gaining attention. We also cover current clinical progress, the potential to combine mRNA vaccines with immunotherapy, and the challenges that remain to be solved before these approaches become routine cancer treatments.

Can peptides help slow the biological processes of aging? In this episode, we explore how anti-aging peptides may influence cellular repair, inflammation, metabolism, collagen production, and tissue regeneration. We examine the scientific evidence, emerging therapeutic applications, and the limitations and safety concerns surrounding peptide-based approaches to healthier aging.

Telomerase helps protect the ends of chromosomes, but its role in aging is complex. In this episode, we explore how telomeres influence cellular lifespan, whether activating telomerase could slow age-related decline, and the scientific and safety challenges that stand between promising research and future anti-aging therapies.